The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy.
Mahaffey
Kenneth W
KW
Becker
Richard C
RC
D000925:Anticoagulants / Q000627:therapeutic use*; D019644:Arthroplasty, Replacement, Hip; D004311:Double-Blind Method; D015951:Factor Xa / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D011184:Postoperative Period; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*
D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban; D015951:Factor Xa